ArticleKorean journal of orthodontics2026
Efficacy and stability of maxillary arch expansion with clear aligners versus conventional slow maxillary expanders in growing patients: A multicenter prospective cohort study.
Article in Korean journal of orthodontics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the efficacy and stability of maxillary arch expansion using clear aligners (CAs) and slow maxillary expanders (SMEs) in growing patients with maxillary transverse deficiency. Methods: This prospective multicenter cohort study included 48 growing patients (mean age, 9.3 ± 1.7 years; CA group: n = 24; SME group: n = 24) requiring maxillary expansion. The maxillary arch dimensions at the crown and gingival levels, arch perimeter, and molar buccolingual inclination were assessed at pretreatment (T0), post-expansion (T1), and post-retention (T2). The primary outcome was intermolar transverse expansion. A predefined non-inferiority analysis was performed to determine whether the expansion achieved with CAs was non-inferior to that achieved with SMEs within a clinically acceptable margin. Secondary analyses assessed the magnitude, pattern, and stability of the expansion through intra-and intergroup comparisons across time points. Results: The average duration of the expansion phase (T0-T1) was 8.9 ± 3.4 months in the CA group and 6.3 ± 6.1 months in the SME group, followed by a retention phase (T1-T2) of 8.8 ± 5.0 and 8.3 ± 5.7 months, respectively. Both groups showed significant increases in the arch dimensions at T0-T1 and T0-T2. The SME group showed a greater bodily expansion pattern in the molars at T0-T2, although this difference was not statistically significant ( Conclusions: Based on a predefined non-inferiority margin, the maxillary arch expansion achieved with CAs was not inferior to that obtained with SMEs in growing patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.